Potential use of folate-appended methyl-β-cyclodextrin as a novel antitumor agent

Drug Delivery System

Volumn 28, Issue 2, 2013, Pages 99-108

  Motoyama, Keiichi ^a   Higashi, Taishi ^a   Arima, Hidetoshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Autophagy; Cancer; Cyclodextrin; Folate receptor; Folic acid

Indexed keywords

EID: 84924766433     PISSN: 09135006     EISSN: 18812732     Source Type: Journal    
DOI: 10.2745/dds.28.99     Document Type: Article

References (28)

1. Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, et al.: Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal. Biochem. 338: 284-293, 2005.
2. Chen H, Ahn R, Van den Bossche J, Thompson DH, O'Halloran TV: Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide. Mol. Cancer Ther. 8: 1955-1963, 2009.
3. Lu Y, Low PS: Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug Deliv. Rev. 54: 675-693, 2002.
4. Bender ML, Komiyama M: "Cyclodextrin Chemistry". Springer-Verlag, Berlin, 1978.
5. Connors KA: The stability of cyclodextrin complexes in solution. Chem. Rev. 97: 1325-1358, 1997.
6. Nabi IR, Le PU: Caveolae/raft-dependent endocytosis. J. Cell Biol. 161: 673-677, 2003.
7. Uekama K: Design and evaluation of cyclodextrin-based drug formulation. Chem. Pharm. Bull. 52: 900-915, 2004.
8. Chaigne-Delalande B, Mahfouf W, Daburon S, Moreau JF, Legembre P: CD95 engagement mediates actin-independent and-dependent apoptotic signals. Cell Death Differ. 16: 1654-1664, 2009.
9. Reis-Sobreiro M, Gajate C, Mollinedo F: Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions. Oncogene 28: 3221-3234, 2009.
10. Ayllon V, Fleischer A, Cayla X, Garcia A, Rebollo A: Segregation of Bad from lipid rafts is implicated in the induction of apoptosis. J. Immunol. 168: 3387-3393, 2002.
11. Fulop T, Larbi A, Douziech N, Fortin C, Guerard KP, et al.: Signal transduction and functional changes in neutrophils with aging. Aging. Cell 3: 217-226, 2004.
12. Motoyama K, Kameyama K, Onodera R, Araki N, Hirayama F, et al.: Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-β-cyclodextrin, not 2,6-di-O-methyl-α-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells. Eur. J. Pharm. Sci. 38: 249-261, 2009.
13. Grosse PY, Bressolle F, Pinguet F: Antiproliferative effect of methyl-β-cyclodextrin in vitro and in human tumour xenografted athymic nude mice. Br. J. Cancer 78: 1165-1169, 1998.
14. Janku F, McConkey JD, Hong SD, Kurzrock R: Autophagy as a target for anticancer therapy. Nat. Rev. Clin. Oncol. 8: 528-539, 2011.
15. Mizushima N, Yoshimori T, Levine B: Methods in mammalian autophagy research. Cell 140: 313-326, 2010.
16. Yan J, Li QF, Wang LS, Wang H, Xiao FJ, et al.: Methyl-β-cyclodextrin induces programmed cell death in chronic myeloid leukemia cells and, combined with imatinib, produces a synergistic downregulation of ERK/SPK1 signaling. Anticancer Drugs 23: 22-31, 2012.
17. Irie T, Uekama K: Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J. Pharm. Sci. 86: 147-162, 1997.
18. Johansen T, Lamark T: Selective autophagy mediated by autophagic adapter proteins. Autophagy 7: 279-296, 2011.
19. Kim I, Lemasters JJ: Mitochondrial degradation by autophagy (mitophagy) in GFP-LC3 transgenic hepatocytes during nutrient deprivation. Am. J. Physiol. Cell Physiol. 300: C308-317, 2011.
20. Garofalo T, Giammarioli AM, Misasi R, Tinari A, Manganelli V, et al.: Lipid microdomains contribute to apoptosis-associated modifications of mitochondria in T cells. Cell Death Differ. 12: 1378-1389, 2005.
21. Garofalo T, Tinari A, Matarrese P, Giammarioli AM, Manganelli V, et al.: Do mitochondria act as "cargo boats" in the journey of GD3 to the nucleus during apoptosis? FEBS Lett. 581: 3899-3903, 2007.
22. Malorni W, Giammarioli AM, Garofalo T, Sorice M: Dynamics of lipid raft components during lymphocyte apoptosis: the paradigmatic role of GD3. Apoptosis 12: 941-949, 2007.
23. Martinez-Abundis E, Garcia N, Correa F, Franco M, Zazueta C: Changes in specific lipids regulate BAX-induced mitochondrial permeability transition. FEBS J. 274: 6500-6510, 2007.
24. Ziolkowski W, Szkatula M, Nurczyk A, Wakabayashi T, Kaczor JJ, et al.: Methyl-β-cyclodextrin induces mitochondrial cholesterol depletion and alters the mitochondrial structure and bioenergetics. FEBS Lett. 584: 4606-4610, 2010.
25. Shacka JJ, Klocke BJ, Roth KA: Autophagy, bafilomycin and cell death: the "a-B-cs" of plecomacrolide-induced neuroprotection. Autophagy 2: 228-230, 2006.
26. Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, et al.: Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct. Funct. 23: 33-42, 1998.
27. Ono A, Hattori S, Kariya R, Iwanaga S, Taura M, et al.: Comparative study of human hematopoietic cell engraftment into BALB/c and C57BL/6 strain of Rag-2/Jak3 double-deficient mice. J. Biomed. Biotechnol. 2011: 539748, 2011.
28. Chauhan VP, Stylianopoulos T, Martin JD, Popovic Z, Chen O, et al.: Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat. Nanotechnol. 7: 383-388, 2012.